Grace Therapeutics, Inc. (GRCE) Stock Price History
Historical prices from 2024 to 2026
Loading 10-year price history...
GRCE Historical Performance
Short-Term Returns
GRCE Stock Price Trajectory (2024–2026)
As of May 8, 2026, Grace Therapeutics, Inc. (GRCE) trades at $2.25, representing a -25.5% return over the past year. The stock has delivered a -25.2% total return over five years (-5.7% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $5.18 on April 2, 2026. From this peak, GRCE has corrected -56.6%, currently trading 34% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers RARE (-21.8% 1Y), FOLD (+137.9% 1Y), and ACAD (+52.4% 1Y), GRCE has underperformed the peer group average. Compare GRCE vs RARE →
GRCE Historical Price Data (2025–2026)
Showing 30 of 402 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 2.37 | 2.40 | 2.22 | 2.25 | 355K | -5.06% |
| 2026-05-06 | 2.41 | 2.56 | 2.35 | 2.37 | 1.40M | +1.72% |
| 2026-05-05 | 2.35 | 2.37 | 2.28 | 2.33 | 295K | -1.27% |
| 2026-05-04 | 2.35 | 2.38 | 2.24 | 2.36 | 405K | +0.85% |
| 2026-05-01 | 2.30 | 2.49 | 2.29 | 2.34 | 786K | +4.46% |
| 2026-04-30 | 2.17 | 2.28 | 2.10 | 2.24 | 739K | +6.67% |
| 2026-04-29 | 2.10 | 2.14 | 2.03 | 2.10 | 473K | 0.00% |
| 2026-04-28 | 2.11 | 2.15 | 2.04 | 2.10 | 582K | -2.78% |
| 2026-04-27 | 2.33 | 2.35 | 2.10 | 2.16 | 1.05M | -6.09% |
| 2026-04-24 | 2.21 | 2.41 | 2.10 | 2.30 | 3.29M | -2.13% |
| 2026-04-23 | 4.34 | 4.64 | 1.79 | 2.35 | 6.41M | -45.48% |
| 2026-04-22 | 4.63 | 4.63 | 4.12 | 4.31 | 1.22M | -7.51% |
| 2026-04-21 | 4.78 | 4.80 | 4.49 | 4.66 | 582K | +1.53% |
| 2026-04-20 | 4.74 | 5.06 | 4.50 | 4.59 | 1.06M | -0.22% |
| 2026-04-17 | 4.58 | 4.98 | 4.53 | 4.60 | 946K | +2.45% |
| 2026-04-16 | 4.36 | 4.57 | 4.05 | 4.49 | 601K | +2.98% |
| 2026-04-15 | 4.30 | 4.75 | 4.30 | 4.36 | 1.08M | +1.87% |
| 2026-04-14 | 4.00 | 4.37 | 3.95 | 4.28 | 743K | +12.04% |
| 2026-04-13 | 3.48 | 3.85 | 3.48 | 3.82 | 568K | +6.41% |
| 2026-04-10 | 3.63 | 3.75 | 3.45 | 3.59 | 409K | -0.83% |
| 2026-04-09 | 3.56 | 3.81 | 3.44 | 3.62 | 568K | +1.40% |
| 2026-04-08 | 3.50 | 3.69 | 3.29 | 3.57 | 818K | +7.21% |
| 2026-04-07 | 4.21 | 4.21 | 2.50 | 3.33 | 5.62M | -18.18% |
| 2026-04-06 | 5.05 | 5.09 | 4.04 | 4.07 | 1.69M | -20.66% |
| 2026-04-02 | 4.80 | 5.18 | 4.70 | 5.13 | 659K | +5.12% |
| 2026-04-01 | 4.65 | 5.05 | 4.65 | 4.88 | 740K | +5.40% |
| 2026-03-31 | 4.36 | 4.69 | 4.35 | 4.63 | 540K | +6.19% |
| 2026-03-30 | 4.65 | 4.68 | 4.32 | 4.36 | 477K | -6.64% |
| 2026-03-27 | 4.78 | 4.91 | 4.59 | 4.67 | 510K | -2.10% |
| 2026-03-26 | 4.69 | 4.85 | 4.55 | 4.77 | 794K | +1.71% |
See GRCE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GRCE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GRCE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGRCE — Frequently Asked Questions
Quick answers to the most common questions about buying GRCE stock.
How has GRCE stock performed recently?
GRCE declined -25.5% over the past year, below its 5-year annualized CAGR of -5.7%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is GRCE's all-time high price?
Grace Therapeutics, Inc. reached $5.18 on 2026-04-02. The 52-week high is $5.18. Current 1-year return of -25.5% places the stock further from historical peaks.
Where can I download GRCE historical price data?
This page provides GRCE daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2024-2026, downloadable in CSV format.